Search alternatives:
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latest decrease » largest decrease (Expand Search), greatest decrease (Expand Search), largest decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a latest » _ latest (Expand Search), a latent (Expand Search), _ latent (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latest decrease » largest decrease (Expand Search), greatest decrease (Expand Search), largest decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a latest » _ latest (Expand Search), a latent (Expand Search), _ latent (Expand Search)
-
1461
-
1462
-
1463
-
1464
-
1465
-
1466
-
1467
-
1468
-
1469
-
1470
-
1471
-
1472
-
1473
Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.
Published 2025“…<p>Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.…”
-
1474
-
1475
-
1476
-
1477
Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils.
Published 2013“…C and D: blocking CD88 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. …”
-
1478
GSK360A increased kidney EPO and brain VEGF mRNA after stroke.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1479
Effect of GSK360A on APA learning performance 3 weeks after tMCAO stroke.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1480
The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”